FIELD: chemistry.
SUBSTANCE: invention relates to organic chemistry and specifically to crystalline form of (S)-1-(4-(dimethylamino)piperidin-1-yl)-3-hydroxy-3-(1-methyl-1H-imidazol-2-yl)propan-1-one, on a powder X-ray diffraction pattern of which there are peaks at diffraction angles of 2θ(°) 15.3 ± 0.2, 16.0 ± 0.2, 19.0 ± 0.2, 21.8 ± 0.2 and 23.0 ± 0.2. Invention also relates to a medicinal analgesic and therapeutic agent based thereon, as well as to a pharmaceutical composition based thereon.
EFFECT: technical result is obtaining a compound in crystalline form having analgesic action.
6 cl, 6 dwg, 7 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CO-CRYSTALLINE FORMS OF TRAMADOL AND NSAID | 2009 |
|
RU2599717C2 |
| CO-CRYSTALS OF TRAMADOL AND COXIBS | 2010 |
|
RU2547830C2 |
| ACID ADDITION SALT OF TRK INHIBITING COMPOUND | 2015 |
|
RU2708236C2 |
| CRYSTAL SUBSTANCE OF HETEROCYCLIDENACETAMIDE DERIVATIVE | 2018 |
|
RU2779198C2 |
| DYNAMIC CYCLIC AMINE AND PHARMACEUTICAL APPLICATION THEREOF | 2016 |
|
RU2667062C1 |
| BENZOTHIOPHENE COMPOUND | 2014 |
|
RU2667507C2 |
| DOSAGE FORMS, SALTS AND POLYMORPHS OF TRANSNORSERTRALINE AND USING THEM | 2010 |
|
RU2578956C2 |
| NEW PREVENTIVE AND/OR THERAPEUTIC AGENT FOR NEUROPATHIC PAIN | 2008 |
|
RU2462459C2 |
| N-(4-FLUOROBENZYL)-N-(1-METHYLPIPERIDIN-4-YL)-N'-(2-METHYLPROPYLOXY)PHENYLMETHYL) CARBAMIDE SALTS AND PREPARATION OF SAID SALTS | 2005 |
|
RU2387643C2 |
| CRYSTALLINE FORM AND TOSYLATE OF TETRACYCLINE COMPOUND, CRYSTALLINE FORM OF SAID TOSYLATE AND POLYMORPH THEREOF, METHOD OF PRODUCING TOSYLATE OF TETRACYCLINE COMPOUND, POLYMORPH OBTAINED USING SAID METHOD, AND PHARMACEUTICAL COMPOSITIONS BASED ON SAID CRYSTALLINE FORM AND POLYMORPH | 2009 |
|
RU2500665C2 |
